Flawed drug tests wrongfully sending new mothers to police: "Scope of this is massive"

Journalists Shoshana Walter and Jill Castellano from The Marshall Project joined CBS News on "The Daily Report" this week to expose how tens of thousands of American mothers have been wrongfully referred to law enforcement and child protective services over the last six years due to flawed drug testing during pregnancy. The investigation reveals a systemic failure within the U.S. healthcare system where preliminary screening tests, which are notorious for producing false positives, are being treated as definitive evidence of substance abuse. This widespread issue has triggered aggressive legal interventions, often resulting in the immediate separation of newborns from their parents or the initiation of criminal proceedings against new mothers based on incorrect data. The scope of the problem is described as "massive," with the reporting highlighting a disturbing lack of standardized confirmation testing. Many hospitals rely on inexpensive immunoassay tests that can be triggered by common legal substances, such as over-the-counter cold medicines or even certain snack foods like poppy seeds. Despite the clinical community's knowledge that these initial screenings are unreliable without follow-up laboratory verification, medical facilities across the country continue to report these unverified results to state agencies, frequently bypassing the due process that would protect families from unnecessary trauma. Furthermore, the impact of these flawed tests is disproportionately felt by marginalized communities, as the investigation suggests that screening protocols are often applied inconsistently. Once a report is filed with law enforcement, the burden of proof shifts to the mother to prove her innocence, a process that can take months or years while her parental rights remain in jeopardy. The collaboration between CBS News and the Marshall Project aims to bring legislative attention to the need for mandatory confirmatory testing and more stringent privacy protections for expectant mothers within the clinical setting.